The analysts' scenario did not include vaccine mitigation nor did it anticipate large-scale infections throughout 2021.
An update to its March 2020 report, Wakely Consulting Group explored the potential COVID-19 treatment cost implications to U.S. private insurance providers for 2020 and 2021 on behalf of America’s Health...